AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9403262 — intervention group
Group type: EXPERIMENTAL
Intervention: Stoxil topical ointment
Number of subjects: 72
Study 9403262 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 72
Study 8427753 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 320 mg I/ml
Number of subjects: 72
Study 8427753 — intervention group
Group type: COMPARATOR
Intervention: Iohexol 350 mg I/ml
Number of subjects: 72
Study 3298649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 21
Study 3298649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 29032139 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily (50 mg once daily if treated with a sulfonylurea)
Number of subjects: 254
Study 29032139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 29032139 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 254
Study 27772790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold air chamber at -60°C (n=12)
Number of subjects: 35
Study 27772790 — intervention group
Group type: EXPERIMENTAL
Intervention: Local cryotherapy at -17°C (n=11)
Number of subjects: 35
Study 27772790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold air chamber at -10°C (n=12)
Number of subjects: 35
Study 24236569 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned baby care education and an education booklet
Number of subjects: 0
Study 24236569 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 22421926 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training (land-based or aquatic-based treadmill): 3 sessions·week(‐1), progressing to 500 kcal·session(‐1) for 12 weeks
Number of subjects: 18
Study 22421926 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise training
Number of subjects: 18
Study 22421926 — intervention group
Group type: COMPARATOR
Intervention: Acute exercise session (70% VO(2)max, 400 kcal energy expenditure)
Number of subjects: 18
Study 20156151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal drug therapy (IP chemotherapy)
Number of subjects: 0
Study 20156151 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal drug therapy
Number of subjects: 0
Study 18458640 — intervention group
Group type: EXPERIMENTAL
Intervention: IdB 1016 (silybin and soy phosphatidylcholine complex)
Number of subjects: 37
Study 17163231 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 72
Study 17163231 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 72
Study 17163231 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 15 mg
Number of subjects: 72
Study 17163231 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 10 mg
Number of subjects: 72
Study 17163231 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 72
Study 17163231 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole
Number of subjects: 72
Study 12668301 — intervention group
Group type: EXPERIMENTAL
Intervention: Dörges universal laryngoscope blade
Number of subjects: 40
Study 12668301 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope blades size 2-4
Number of subjects: 40
Study 10723115 — intervention group
Group type: EXPERIMENTAL
Intervention: tibolone 2.5 mg
Number of subjects: 29
Study 10723115 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 29
Study 9364183 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled beclomethasone 1000 micrograms twice daily for three months
Number of subjects: 18
Study 9364183 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone 30 mg/day for ten days after each treatment phase
Number of subjects: 18
Study 9364183 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study 1493986 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg ciprofloxacin
Number of subjects: 62
Study 1493986 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg ciprofloxacin
Number of subjects: 62
Study 1493986 — intervention group
Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 62
Study 1493986 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (both dosages)
Number of subjects: 62
Study 2419692 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil 37.5 mg
Number of subjects: 0
Study 2419692 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil 37.5 mg + Propranolol 40 mg
Number of subjects: 0
Study 2419692 — intervention group
Group type: COMPARATOR
Intervention: Propranolol 40 mg
Number of subjects: 0
Study 30522481 — intervention group
Group type: EXPERIMENTAL
Intervention: PPFP and PPIUD training
Number of subjects: 14
Study 27180341 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula 42 (F42)
Number of subjects: 10
Study 27180341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 24532106 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) at STN site
Number of subjects: 37
Study 24532106 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Brain Stimulation (DBS) at GPi site
Number of subjects: 37
Study 24532106 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS ON
Number of subjects: 37
Study 24532106 — intervention group
Group type: COMPARATOR
Intervention: Control group (no surgery)
Number of subjects: 37
Study 22742717 — intervention group
Group type: EXPERIMENTAL
Intervention: dobutamine
Number of subjects: 21
Study 22742717 — intervention group
Group type: EXPERIMENTAL
Intervention: terbutaline
Number of subjects: 21
Study 20394495 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of azelaic acid 5% and erythromycin 2% gel (AzE)
Number of subjects: 147
Study 20394495 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin 2%
Number of subjects: 147
Study 20394495 — intervention group
Group type: COMPARATOR
Intervention: Azelaic acid 20%
Number of subjects: 147
Study 20394495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 18661887 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein, high-caloric supplement (3 daily servings)
Number of subjects: 50
Study 18661887 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 50
Study 15844010 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced walking (15-20 min, low intensity)
Number of subjects: 15
Study 15844010 — intervention group
Group type: COMPARATOR
Intervention: Control condition (passive sitting)
Number of subjects: 15
Study 11803323 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (2 mg/kg x min)
Number of subjects: 22
Study 11803323 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 22
Study 10528377 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrel-Dubousset instrumentation (rod rotation)
Number of subjects: 70
Study 10528377 — intervention group
Group type: COMPARATOR
Intervention: Colorado instrumentation (translation)
Number of subjects: 70
Study 8720289 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b and ribavirin
Number of subjects: 20
Study 2040233 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 132
Study 2040233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 6274580 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise exposure (100 dBA) for 10 min
Number of subjects: 0
Study 6274580 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise exposure during non-selective beta-adrenoceptor blockade (propranolol)
Number of subjects: 0
Study 6274580 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 min of quiet rest at 40 dBA after noise exposure
Number of subjects: 0
Study 6274580 — intervention group
Group type: COMPARATOR
Intervention: beta 1-selective adrenoceptor blockade (metoprolol)
Number of subjects: 0
Study 29733230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 413
Study 29733230 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 413
Study 29733230 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 413
Study 31350658 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation of fearful faces for 30 seconds
Number of subjects: 24
Study 31350658 — intervention group
Group type: COMPARATOR
Intervention: Observation of neutral image (white screen) for 30 seconds
Number of subjects: 24
Study 31350658 — intervention group
Group type: COMPARATOR
Intervention: Observation of any image
Number of subjects: 24
Study 28297053 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 0
Study 28297053 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 0
Study 25683312 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative rehabilitation intervention during hospitalization (PG)
Number of subjects: 60
Study 25683312 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study 25145522 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP <140 mm Hg (group 1)
Number of subjects: 8354
Study 25145522 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP 140 to <150 mm Hg (group 2)
Number of subjects: 8354
Study 25145522 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic BP ≥150 mm Hg (group 3)
Number of subjects: 8354
Study 22211362 — intervention group
Group type: COMPARATOR
Intervention: High dose of cloprostenol (87.5 μg; 1.0 ml; i.m.)
Number of subjects: 48
Study 22211362 — intervention group
Group type: EXPERIMENTAL
Intervention: Half dose of cloprostenol (43.75 μg; 0.5 ml)
Number of subjects: 48
Study 22211362 — intervention group
Group type: EXPERIMENTAL
Intervention: One third dose of cloprostenol (26.25 μg; 0.3 ml)
Number of subjects: 48
Study 19205289 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) for 5 years
Number of subjects: 51
Study 19205289 — intervention group
Group type: COMPARATOR
Intervention: Inhaled budesonide, 800 microg/d during pollen season
Number of subjects: 51
Study 17765649 — intervention group
Group type: EXPERIMENTAL
Intervention: AFA extract
Number of subjects: 12
Study 15469451 — intervention group
Group type: EXPERIMENTAL
Intervention: Eletriptan 80 mg
Number of subjects: 123
Study 15469451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 11605103 — intervention group
Group type: EXPERIMENTAL
Intervention: High soya diet (100 mg total isoflavones/day)
Number of subjects: 0
Study 11605103 — intervention group
Group type: COMPARATOR
Intervention: Low soya diet (0.5 mg total isoflavones/day)
Number of subjects: 0
Study 9623031 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone, final dose 6 mg
Number of subjects: 120
Study 8076566 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel applied to the throat for 20 minutes
Number of subjects: 20
Study 8076566 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine solution administered by gargling for five minutes
Number of subjects: 20
Study 2692588 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 18
Study 2692588 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 18
Study 2692588 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 1091183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of haloperidol
Number of subjects: 62
Study 1091183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 31843007 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard RRT strategy (RRT initiated within 12 hours)
Number of subjects: 270
Study 31843007 — intervention group
Group type: COMPARATOR
Intervention: Delayed RRT strategy (RRT initiated only if a potentially severe condition occurs or serum urea concentration reaches 50 mmol/l)
Number of subjects: 270
Study 26611718 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg/day omega-3 fatty acid from flaxseed oil
Number of subjects: 60
Study 26611718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 25839731 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy food brand placement
Number of subjects: 3
Study 25839731 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint use of advertising and brand placement
Number of subjects: 3
Study 25839731 — intervention group
Group type: COMPARATOR
Intervention: Control group (no brand placement)
Number of subjects: 3
Study 23948819 — intervention group
Group type: EXPERIMENTAL
Intervention: NWB bi-weekly group exercise class
Number of subjects: 40
Study 21106663 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-varying abstinence
Number of subjects: 236
Study 21106663 — intervention group
Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 236
Study 19336785 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine psychosocial care and selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 192
Study 19336785 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine psychosocial care, selective serotonin reuptake inhibitors (SSRIs), and cognitive-behavioural therapy (CBT)
Number of subjects: 192
Study 16770244 — intervention group
Group type: EXPERIMENTAL
Intervention: WOFIE group (interruption of immunosuppression for 72 hr)
Number of subjects: 40
Study 16770244 — intervention group
Group type: EXPERIMENTAL
Intervention: WOFIE group
Number of subjects: 40
Study 16770244 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 16770244 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study 14742989 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus and sirolimus (Group A)
Number of subjects: 150
Study 14742989 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus and mycophenolate mofetil (MMF) (Group B)
Number of subjects: 150
Study 14742989 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine A (CsA) and sirolimus (Group C)
Number of subjects: 150
Study 11775133 — intervention group
Group type: EXPERIMENTAL
Intervention: COER-verapamil (180 to 540 mg/day)
Number of subjects: 398
Study 11775133 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 398
Study 11775133 — intervention group
Group type: EXPERIMENTAL
Intervention: COER-verapamil (in women)
Number of subjects: 398
Study 11775133 — intervention group
Group type: EXPERIMENTAL
Intervention: COER-verapamil (in older patients)
Number of subjects: 398
Study 9835829 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium nitrate/PCC dentifrice
Number of subjects: 48
Study 9835829 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice without potassium nitrate
Number of subjects: 48
Study 7986516 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous verapamil
Number of subjects: 20
Study 7986516 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 20
Study 7986516 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine-verapamil mixture
Number of subjects: 20
Study 7986516 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 20
Study 2648230 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen shields applied post-keratoplasty
Number of subjects: 89
Study 29703004 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational-emotive stress management intervention
Number of subjects: 54
Study 29703004 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 54
Study 28237535 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (FO) 3g/day
Number of subjects: 20
Study 28237535 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil (PO)
Number of subjects: 20
Study 28237535 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratification by membrane n-3 PUFA content
Number of subjects: 20
Study 25652104 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg nebulized magnesium
Number of subjects: 365
Study 25652104 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 365
Study 21353794 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (50 Gy/25 Fs/5 wk)
Number of subjects: 100
Study 21353794 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy (50 Gy/25 Fs/5 wk)
Number of subjects: 100
Study 21321641 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus thiotepa (TXT/TSPA)
Number of subjects: 46
Study 21321641 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel plus capecitabine (TXT/CAPE)
Number of subjects: 46
Study 19080649 — intervention group
Group type: EXPERIMENTAL
Intervention: Firebird DES implantation and Tirofiban intravenous injection (10 microg x kg(‐1) within 3 minutes followed by 0.15 microg x kg(‐1) x min(‐1) for 36 hours)
Number of subjects: 323
Study 19080649 — intervention group
Group type: COMPARATOR
Intervention: Cypher DES implantation and Tirofiban
Number of subjects: 323
Study 12551672 — intervention group
Group type: EXPERIMENTAL
Intervention: IOLMaster optical instrument (Carl Zeiss)
Number of subjects: 134
Study 12551672 — intervention group
Group type: COMPARATOR
Intervention: Ultrascan Digital 2000 contact ultrasound A-scan (Alcon)
Number of subjects: 134
Study 10663020 — intervention group
Group type: EXPERIMENTAL
Intervention: PDWHF (platelet derived wound healing factors)
Number of subjects: 15
Study 10663020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 10663020 — intervention group
Group type: EXPERIMENTAL
Intervention: PDWHF
Number of subjects: 15
Study 7825541 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet B (21% of total energy intake)
Number of subjects: 29
Study 7825541 — intervention group
Group type: COMPARATOR
Intervention: Diet A (12% of total energy intake)
Number of subjects: 29
Study 2208024 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarterial cisplatin (DDP) with systemic doxorubicin, high-dose methotrexate, and ifosfamide
Number of subjects: 109
Study 2208024 — intervention group
Group type: COMPARATOR
Intervention: Intravenous cisplatin (DDP) with systemic doxorubicin, high-dose methotrexate, and ifosfamide
Number of subjects: 109
Study 38180 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (specifics not provided)
Number of subjects: 0
Study 31915045 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS
Number of subjects: 60
Study 31915045 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 31202506 — intervention group
Group type: EXPERIMENTAL
Intervention: 50-mg udenafil BID
Number of subjects: 63
Study 31202506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 27115565 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 sessions of one-on-one tele-interpersonal psychotherapy (tele-IPT)
Number of subjects: 132
Study 27115565 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 132
Study 25936684 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (71ml) GRE acquisitions
Number of subjects: 10
Study 25936684 — intervention group
Group type: COMPARATOR
Intervention: Low-dose (24ml) GRE scans
Number of subjects: 10
Study 25936684 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (71ml) 3D-radial acquisitions
Number of subjects: 10
Study 25936684 — intervention group
Group type: COMPARATOR
Intervention: Low-dose (24ml) 3D-radial acquisitions
Number of subjects: 10
Study 25936684 — intervention group
Group type: EXPERIMENTAL
Intervention: All scans
Number of subjects: 10
Study 24169052 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (BUD), 800 micrograms
Number of subjects: 48
Study 24169052 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 48
Study 21843696 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice group (various condom types)
Number of subjects: 1274
Study 21843696 — intervention group
Group type: COMPARATOR
Intervention: Control group (one type of condom)
Number of subjects: 1274
Study 19927459 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17921131 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE D allele carriers
Number of subjects: 248
Study 17921131 — intervention group
Group type: EXPERIMENTAL
Intervention: APO E epsilon 4 allele carriers
Number of subjects: 248
Study 17921131 — intervention group
Group type: EXPERIMENTAL
Intervention: AGTR1 C allele carriers
Number of subjects: 248
Study 17921131 — intervention group
Group type: COMPARATOR
Intervention: A allele homozygotes
Number of subjects: 248
Study 15822550 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 28
Study 15822550 — intervention group
Group type: COMPARATOR
Intervention: Aspiration combined with methylprednisolone acetate injection plus wrist immobilization
Number of subjects: 28
Study 11157319 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 186
Study 11157319 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 186
Study 11157319 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise
Number of subjects: 186
Study 11157319 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 186
Study 9762674 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 61
Study 9762674 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐beta 1a (IFN‐beta 1a)
Number of subjects: 61
Study 9762674 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (CST)
Number of subjects: 61
Study 9762674 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 61
Study 9762674 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 61
Study 8160980 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (28 degrees C) in Group H
Number of subjects: 23
Study 8160980 — intervention group
Group type: COMPARATOR
Intervention: Normothermia in Group N
Number of subjects: 23
Study 8160980 — intervention group
Group type: COMPARATOR
Intervention: Mannitol 0.5 g/kg in Group M
Number of subjects: 23
Study 29379095 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (40mg)
Number of subjects: 14